Sintx Technologies (SINT) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.58% |
| Dec 31, 2025 | -19.92% |
| Sep 30, 2025 | -24.40% |
| Jun 30, 2025 | -30.83% |
| Mar 31, 2025 | -25.02% |
| Dec 31, 2024 | -39.05% |
| Sep 30, 2024 | -33.80% |
| Jun 30, 2024 | -25.60% |
| Mar 31, 2024 | -25.07% |
| Dec 31, 2023 | -30.21% |
| Sep 30, 2023 | -27.05% |
| Jun 30, 2023 | -10.39% |
| Mar 31, 2023 | 12.47% |
| Dec 31, 2022 | 3.12% |
| Sep 30, 2022 | 16.03% |
| Jun 30, 2022 | 23.23% |
| Mar 31, 2022 | 28.76% |
| Dec 31, 2021 | 26.98% |
| Sep 30, 2021 | 33.48% |
| Jun 30, 2021 | 23.84% |
| Mar 31, 2021 | 57.97% |
| Dec 31, 2020 | 68.00% |
| Sep 30, 2020 | 1,281.66% |
| Jun 30, 2020 | 1,060.98% |
| Mar 31, 2020 | 830.51% |
| Dec 31, 2019 | -22.64% |
| Sep 30, 2019 | -19.38% |
| Jun 30, 2019 | -12.92% |
| Dec 31, 2018 | -16.32% |
| Sep 30, 2018 | 88.63% |
| Jun 30, 2018 | 11.49% |
| Mar 31, 2018 | 23.46% |
| Dec 31, 2017 | -7.64% |
| Sep 30, 2017 | -90.44% |
| Jun 30, 2017 | -90.62% |
| Mar 31, 2017 | -91.21% |
| Dec 31, 2016 | 27.51% |